Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

10 Stocks Moving In Tuesday's Pre-Market Session

GRPN, FCX, EXE, RGLS


Gainers

  • ReachLocal Inc. (NASDAQ: RLOC) rose 170.57 percent to $4.57 in pre-market trading after Gannett Co Inc (NYSE: GCI) announced its plans to acquire ReachLocal for $4.60 per share.
  • Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.05 percent to $2.55 in pre-market trading after falling 15.41 percent on Monday.
  • Immunomedics, Inc. (NASDAQ: IMMU) shares rose 7.50 percent to $2.15 in pre-market trading after the company announced a patent for sacituzumab govitecan.
  • Lannett Company, Inc. (NYSE: LCI) shares rose 5.2 percent to $24.00 in pre-market trading after the company reported the FDA approval for Diazepam Oral Solution, 5 mg/5 mL.
  • Chesapeake Energy Corporation (NYSE: CHK) shares rose 4.93 percent to $4.26 in pre-market trading after declining 7.09 percent on Monday.
  • Freeport-McMoRan Inc (NYSE: FCX) rose 4.44 percent to $10.58 in pre-market trading after falling 4.25 percent on Monday.
  • Groupon Inc (NASDAQ: GRPN) rose 3.69 percent to $3.09 in pre-market trading after dropping 5.10 percent on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Regulus Therapeutics Inc (NASDAQ: RGLS) shares fell 52.10 percent to $2.40 after the FDA said it had placed the company’s lead product candidate, RG-101 for the treatment of hepatitis C virus (HCV) infection, on clinical hold.
  • Blue Buffalo Pet Products Inc (NASDAQ: BUFF) shares fell 3.08 percent to $22.66 in pre-market trading. Blue Buffalo filed to offer 15 million shares.
  • Randgold Resources Ltd. (ADR) (NASDAQ: GOLD) shares tumbled 2.1 percent to $104.69 in the pre-market trading session after rising 5.66 percent on Monday.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today